Green Cross (005250) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Green Cross (005250) has a cash flow conversion efficiency ratio of 0.074x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩139.95 Billion ≈ $94.84 Million USD) by net assets (₩1.89 Trillion ≈ $1.28 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can Green Cross fund operations to measure how many days the company can operate on defensive assets alone.
Green Cross - Cash Flow Conversion Efficiency Trend (2000–2024)
This chart illustrates how Green Cross's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Green Cross Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Green Cross ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Xinjiang West Animal Husbandry
SHE:300106
|
0.027x |
|
Platinum Capital Ltd
AU:PMC
|
0.029x |
|
Nordic Paper Holding AB
ST:NPAPER
|
0.115x |
|
KS Terminals Inc
TW:3003
|
0.040x |
|
Weyco Group Inc
NASDAQ:WEYS
|
0.072x |
|
Dhani Services Limited
NSE:DHANI
|
0.010x |
|
Cogstate Ltd
AU:CGS
|
0.235x |
|
Elmera Group ASA
OL:ELMRA
|
-0.633x |
Annual Cash Flow Conversion Efficiency for Green Cross (2000–2024)
The table below shows the annual cash flow conversion efficiency of Green Cross from 2000 to 2024. For the full company profile with market capitalisation and key ratios, see Green Cross market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩1.85 Trillion ≈ $1.26 Billion |
₩-89.95 Billion ≈ $-60.96 Million |
-0.049x | -130.42% |
| 2023-12-31 | ₩1.88 Trillion ≈ $1.28 Billion |
₩-39.65 Billion ≈ $-26.87 Million |
-0.021x | -142.67% |
| 2022-12-31 | ₩1.97 Trillion ≈ $1.33 Billion |
₩97.16 Billion ≈ $65.84 Million |
0.049x | -9.05% |
| 2021-12-31 | ₩1.91 Trillion ≈ $1.29 Billion |
₩103.77 Billion ≈ $70.32 Million |
0.054x | +154.07% |
| 2020-12-31 | ₩1.67 Trillion ≈ $1.13 Billion |
₩35.77 Billion ≈ $24.24 Million |
0.021x | +320.95% |
| 2019-12-31 | ₩1.51 Trillion ≈ $1.02 Billion |
₩7.65 Billion ≈ $5.18 Million |
0.005x | -80.40% |
| 2018-12-31 | ₩1.45 Trillion ≈ $984.76 Million |
₩37.64 Billion ≈ $25.51 Million |
0.026x | -74.19% |
| 2017-12-31 | ₩1.44 Trillion ≈ $975.64 Million |
₩144.48 Billion ≈ $97.91 Million |
0.100x | +17256.99% |
| 2016-12-31 | ₩1.38 Trillion ≈ $933.18 Million |
₩-805.47 Million ≈ $-545.86K |
-0.001x | -110.87% |
| 2015-12-31 | ₩1.31 Trillion ≈ $885.99 Million |
₩7.04 Billion ≈ $4.77 Million |
0.005x | -88.35% |
| 2014-12-31 | ₩1.18 Trillion ≈ $800.39 Million |
₩54.54 Billion ≈ $36.96 Million |
0.046x | +189.06% |
| 2013-12-31 | ₩1.10 Trillion ≈ $745.23 Million |
₩17.57 Billion ≈ $11.91 Million |
0.016x | -57.76% |
| 2012-12-31 | ₩972.83 Billion ≈ $659.27 Million |
₩36.80 Billion ≈ $24.94 Million |
0.038x | -70.84% |
| 2011-12-31 | ₩895.76 Billion ≈ $607.04 Million |
₩116.18 Billion ≈ $78.73 Million |
0.130x | -69.37% |
| 2010-12-31 | ₩839.83 Billion ≈ $569.14 Million |
₩355.62 Billion ≈ $241.00 Million |
0.423x | -54.13% |
| 2009-12-31 | ₩522.78 Billion ≈ $354.28 Million |
₩482.60 Billion ≈ $327.05 Million |
0.923x | +93.20% |
| 2008-12-31 | ₩350.47 Billion ≈ $237.51 Million |
₩167.47 Billion ≈ $113.49 Million |
0.478x | -36.16% |
| 2007-12-31 | ₩351.08 Billion ≈ $237.92 Million |
₩262.77 Billion ≈ $178.07 Million |
0.748x | +59.53% |
| 2006-12-31 | ₩221.73 Billion ≈ $150.26 Million |
₩104.03 Billion ≈ $70.50 Million |
0.469x | +78.48% |
| 2005-12-31 | ₩236.96 Billion ≈ $160.59 Million |
₩62.29 Billion ≈ $42.22 Million |
0.263x | -69.80% |
| 2003-12-31 | ₩210.22 Billion ≈ $142.46 Million |
₩182.96 Billion ≈ $123.99 Million |
0.870x | +648.32% |
| 2001-12-31 | ₩273.93 Billion ≈ $185.64 Million |
₩31.86 Billion ≈ $21.59 Million |
0.116x | -39.13% |
| 2000-12-31 | ₩282.15 Billion ≈ $191.21 Million |
₩53.91 Billion ≈ $36.53 Million |
0.191x | -- |
About Green Cross
Green Cross Holdings Corporation operates as a biotechnology company. The company provides prescription drugs and over the counter drugs; aseptic fill and finish services for drug manufacturing; and pharmaceutical logistics services. It also researches and develops plasma derivatives for von Willebrand disease and primary immunodeficiency; vaccines for mRNA flu, anthrax, tetanus, diphtheria, pert… Read more